Catalyst Biosciences, Inc. (CBIO)
(Delayed Data from NSDQ)
$8.46 USD
+0.26 (3.17%)
Updated May 3, 2019 04:00 PM ET
After-Market: $8.45 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.46 USD
+0.26 (3.17%)
Updated May 3, 2019 04:00 PM ET
After-Market: $8.45 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
These 5 Stocks Make Great Buys on New Analyst Coverage
by Zacks Equity Research
Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.
Zacks.com featured highlights include: Hilton Grand, Fastenal, Catalyst Biosciences, OpGen and ConforMIS
by Zacks Equity Research
Zacks.com featured highlights include: Hilton Grand, Fastenal, Catalyst Biosciences, OpGen and ConforMIS
Catalyst Biosciences (CBIO) Enters Oversold Territory
by Zacks Equity Research
Catalyst Biosciences, Inc. (CBIO) has been on a bit of a cold streak lately
Implied Volatility Surging for Catalyst Biosciences (CBIO) Stock Options
by Zacks Equity Research
Catalyst Biosciences (CBIO) needs investors to pay close attention to the stock based on moves in the options market lately.
Zacks.com featured highlights include: Unisys, Catalyst, Liberty and New Mountain
by Zacks Equity Research
Zacks.com featured highlights include: Unisys, Catalyst, Liberty and New Mountain
4 Stocks to Bet on New Analyst Coverage
by Zacks Equity Research
More analyst coverage over the last few weeks might translate into solid price appreciation for these stocks.
Bear of the Day: AMAG Pharmaceuticals (AMAG)
by Brian Hamilton
Licensing expenses, increased SG&A, and limited market share expansion are weighing this stock down.
Zacks.com featured highlights: PTC Therapeutics, Catalyst Biosciences, U.S. Silica Holdings, DXC Technology and Patterson-UTI Energy
by Zacks Equity Research
Zacks.com featured highlights: PTC Therapeutics, Catalyst Biosciences, U.S. Silica Holdings, DXC Technology and Patterson-UTI Energy
5 Stocks with Earnings Acceleration to Buy Now
by Tirthankar Chakraborty
Earnings acceleration should be viewed as a key metric for share price outperformance